Metabolic and cardiovascular effects of early insulin glargin prescription: based on data from ORIGIN study

We discuss results of ORIGIN, a multicenter parallel groups study for efficiency assessment of insulin glargin against polyunsaturatedomega-3 fatty acids or placebo regarding cardiovascular and/or mortality risk reduction in patients with impaired fasting glycemia,impaired glucose tolerance or type...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Elena Valer'evna Biryukova, Alexander Sergeevich Ametov, Mikhail Borisovich Antsiferov, Alsu Gafurovna Zalevskaya, Galina Afanas'evna Mel'nichenko, Ashot Musaelovich Mkrtumyan, Marina Vladimirovna Shestakova
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2012
Materias:	prediabetes diabetes mellitus hypoglycemia oncology onsulin glargin origin study Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/b7e6d26cdbee4110988b38b6e29a334f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Metabolic and cardiovascular effects of early insulin glargin prescription: based on data from ORIGIN study

Ejemplares similares